201 related articles for article (PubMed ID: 25025909)
1. Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.
Kaur H; Jajodia A; Grover S; Baghel R; Gupta M; Jain S; Kukreti R
PLoS One; 2014; 9(7):e102556. PubMed ID: 25025909
[TBL] [Abstract][Full Text] [Related]
2. Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.
Kaur H; Jajodia A; Grover S; Baghel R; Jain S; Kukreti R
Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):635-46. PubMed ID: 25209194
[TBL] [Abstract][Full Text] [Related]
3. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
[TBL] [Abstract][Full Text] [Related]
4. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).
Thiselton DL; Maher BS; Webb BT; Bigdeli TB; O'Neill FA; Walsh D; Kendler KS; Riley BP
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):323-31. PubMed ID: 19475563
[TBL] [Abstract][Full Text] [Related]
6. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study.
Xu M; Li S; Xing Q; Gao R; Feng G; Lin Z; St Clair D; He L
Eur J Hum Genet; 2010 Jun; 18(6):707-12. PubMed ID: 20087404
[TBL] [Abstract][Full Text] [Related]
8. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.
Yu H; Yan H; Wang L; Li J; Tan L; Deng W; Chen Q; Yang G; Zhang F; Lu T; Yang J; Li K; Lv L; Tan Q; Zhang H; Xiao X; Li M; Ma X; Yang F; Li L; Wang C; Li T; Zhang D; Yue W;
Lancet Psychiatry; 2018 Apr; 5(4):327-338. PubMed ID: 29503163
[TBL] [Abstract][Full Text] [Related]
9. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
[TBL] [Abstract][Full Text] [Related]
10. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
Yamanouchi Y; Iwata N; Suzuki T; Kitajima T; Ikeda M; Ozaki N
Pharmacogenomics J; 2003; 3(6):356-61. PubMed ID: 14610521
[TBL] [Abstract][Full Text] [Related]
11. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE
J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343
[TBL] [Abstract][Full Text] [Related]
12. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
[TBL] [Abstract][Full Text] [Related]
13. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.
Campbell DB; Ebert PJ; Skelly T; Stroup TS; Lieberman J; Levitt P; Sullivan PF
Biol Psychiatry; 2008 Jan; 63(1):32-41. PubMed ID: 17588543
[TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
15. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
[TBL] [Abstract][Full Text] [Related]
16. Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.
Shi Y; Li M; Song C; Xu Q; Huo R; Shen L; Xing Q; Cui D; Li W; Zhao J; He L; Qin S
Transl Psychiatry; 2017 Jul; 7(7):e1170. PubMed ID: 28696411
[TBL] [Abstract][Full Text] [Related]
17. Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.
Yang Y; Li W; Zhao J; Zhang H; Song X; Xiao B; Yang G; Jiang C; Zhang D; Yue W; Lv L
Behav Brain Funct; 2012 Feb; 8():11. PubMed ID: 22369141
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
19. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
[TBL] [Abstract][Full Text] [Related]
20. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia.
Bakker SC; Hoogendoorn ML; Hendriks J; Verzijlbergen K; Caron S; Verduijn W; Selten JP; Pearson PL; Kahn RS; Sinke RJ
Genes Brain Behav; 2007 Mar; 6(2):113-9. PubMed ID: 17410640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
